Rani Therapeutics Insider Trades
NASDAQ: RANIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 2 · $50.03K
- Sales
- 1 · $301.08
- Shares bought / sold
- 71.00K / 386
- Net activity
- Net buying $49,732
Rani Therapeutics insider activity
Over the last 12 months, Rani Therapeutics insiders reported 10 transactions on SEC Form 4: 2 open-market purchases and 1 sale. Insiders bought $50,033 and sold $301 worth of stock, for net insider buying of $49,732. The largest seller was Javadi Alireza, with $301 in reported sales.
The most recent filing shows Imran Talat (Chief Executive Officer) reporting a transaction in 7,928 shares at $0.7592 on Sep 27, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put RANI's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
RANI insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 27, 2026 | Javadi AlirezaChief Technical Officer | Tax withholding | 309 | $234.59 | Form 4 |
| Sep 27, 2026 | Imran TalatChief Executive Officer | Tax withholding | 7,928 | $6.02K | Form 4 |
| Jul 21, 2026 | IMRAN MIR ADirector | Buy | 36,000 | $24.84K | Form 4 |
| Jul 17, 2026 | Imran TalatChief Executive Officer | Buy | 35,000 | $25.19K | Form 4 |
| Jun 27, 2026 | Javadi AlirezaChief Technical Officer | Tax withholding | 309 | $228.66 | Form 4 |
| Jun 27, 2026 | Imran TalatChief Executive Officer | Tax withholding | 7,927 | $5.87K | Form 4 |
| Mar 27, 2026 | Javadi AlirezaChief Technical Officer | Sale | 386 | $301.08 | Form 4 |
| Mar 27, 2026 | Imran TalatChief Executive Officer | Tax withholding | 9,099 | $7.37K | Form 4 |
| Mar 22, 2026 | Imran TalatChief Executive Officer | Tax withholding | 8,916 | $10.08K | Form 4 |
| Dec 27, 2025 | Imran TalatChief Executive Officer | Tax withholding | 7,906 | $11.07K | Form 4 |
| Oct 23, 2025 | IMRAN MIR ADirector | Buy | 2,083,334 | $1.26M | Form 4 |
| Oct 21, 2025 | South Cone Investments Limited Partnership10% Owner | Sale | 4,000,000 | $11.07M | Form 4 |
| Oct 20, 2025 | South Cone Investments Limited Partnership10% Owner | Sale | 1,923,000 | $4.64M | Form 4 |
| Sep 27, 2025 | Imran TalatChief Executive Officer | Tax withholding | 9,077 | $4.36K | Form 4 |
| Jun 27, 2025 | Imran TalatChief Executive Officer | Tax withholding | 9,076 | $4.99K | Form 4 |
| Dec 27, 2024 | Imran TalatChief Executive Officer | Sale | 8,014 | $11.30K | Form 4 |
| Dec 13, 2024 | McKinley KateChief Business Officer | Buy | 17,960 | $29.99K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4